News

Nishizuka gave an introduction on business plan using OTS-Probes at the 2nd breakout session, “Healthcare and Health Tech,” of the Iwate International Innovation Convention (Morioka).

Kumiko Umemoto, MD, PhD, from St. Marianna University School of Medicine, Takeshi Iwaya, MD, PhD, from Iwate Medical University, and Nishizuka gave a presentation on the research using OTS-Assay at the 64th Annual Meeting of the Japan Society of Clinical Oncology (Kobe).

Nishizuka gave a talk on the research using OTS-Assay at Symposium 2 of the 30th Annual Meeting of the Japanese Society of Surgical Pathology (Tokyo).

Hayato Hiraki, PhD, from Iwate Medical University gave a presentation on the OTS-Assay at the 85th Annual Meeting of the Japanese Cancer Association (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the 85th Annual Meeting of the Japanese Cancer Association (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the Special Symposium of the 46th Annual Meeting of the Japanese Society of Molecular Tumor Markers (Kyoto).

Nishizuka gave a talk on the OTS-Assay at the 8th Multi-Site Joint Medical Conference (Online).

Takeshi Iwaya, MD, PhD, from the Department of Clinical Oncology, Iwate Medical University, and Nishizuka gave a talk at ISDE2026, the 22nd World Congress for Esophageal Diseases (Kyoto).

Nishizuka gave a talk in Innovator’s Pitch Challenge at RESI SAN DIEGO 2026(San Diego, USA)。

Takeshi Iwaya, M.D., Ph.D. from the Department of Clinical Oncology, Iwate Medical University, presented an interim analysis of a prospective randomized trial using OTS-Assay (CHANGE study) at the 23rd Annual Meeting of the Japanese Society of Medical Oncology.